AR019948A1 - Parche que contiene sustancia activa, para la emision controlada de estradiol o sus derivados farmaceuticamente inofensivos, y los usos del parche - Google Patents

Parche que contiene sustancia activa, para la emision controlada de estradiol o sus derivados farmaceuticamente inofensivos, y los usos del parche

Info

Publication number
AR019948A1
AR019948A1 ARP990103731A ARP990103731A AR019948A1 AR 019948 A1 AR019948 A1 AR 019948A1 AR P990103731 A ARP990103731 A AR P990103731A AR P990103731 A ARP990103731 A AR P990103731A AR 019948 A1 AR019948 A1 AR 019948A1
Authority
AR
Argentina
Prior art keywords
patch
containing active
estradiol
derivatives
pharmaceutically
Prior art date
Application number
ARP990103731A
Other languages
English (en)
Spanish (es)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR019948A1 publication Critical patent/AR019948A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
ARP990103731A 1998-07-29 1999-07-28 Parche que contiene sustancia activa, para la emision controlada de estradiol o sus derivados farmaceuticamente inofensivos, y los usos del parche AR019948A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19834006A DE19834006A1 (de) 1998-07-29 1998-07-29 Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen

Publications (1)

Publication Number Publication Date
AR019948A1 true AR019948A1 (es) 2002-03-27

Family

ID=7875612

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103731A AR019948A1 (es) 1998-07-29 1999-07-28 Parche que contiene sustancia activa, para la emision controlada de estradiol o sus derivados farmaceuticamente inofensivos, y los usos del parche

Country Status (14)

Country Link
EP (1) EP1100478A1 (de)
JP (1) JP2002521426A (de)
KR (1) KR20010072071A (de)
CN (1) CN1310615A (de)
AR (1) AR019948A1 (de)
AU (1) AU762589B2 (de)
BR (1) BR9912688A (de)
CA (1) CA2338861A1 (de)
DE (1) DE19834006A1 (de)
IL (1) IL141032A0 (de)
PL (1) PL345696A1 (de)
TR (1) TR200100290T2 (de)
WO (1) WO2000006130A1 (de)
ZA (1) ZA200100721B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005047906A (ja) * 2003-07-16 2005-02-24 Taisho Pharmaceut Co Ltd 外用消炎鎮痛剤組成物
KR100689534B1 (ko) * 2005-05-18 2007-03-02 삼성전자주식회사 휴대 단말기

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis
AU692504B2 (en) * 1993-12-27 1998-06-11 Akzo Nobel N.V. Percutaneously absorbable preparation
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
ZA200100721B (en) 2002-05-27
TR200100290T2 (tr) 2001-07-23
CA2338861A1 (en) 2000-02-10
CN1310615A (zh) 2001-08-29
AU762589B2 (en) 2003-06-26
BR9912688A (pt) 2001-11-27
JP2002521426A (ja) 2002-07-16
EP1100478A1 (de) 2001-05-23
DE19834006A1 (de) 2000-02-24
IL141032A0 (en) 2002-02-10
KR20010072071A (ko) 2001-07-31
WO2000006130A1 (de) 2000-02-10
PL345696A1 (en) 2002-01-02
AU5284299A (en) 2000-02-21

Similar Documents

Publication Publication Date Title
AR021459A1 (es) PARCHE QUE CONTIENE ESTRADIOL PARA LA APLICACIoN PERCUTÁNEA DE HORMONAS.
ES2702231T3 (es) Apósitos que contienen principio activo
US6890553B1 (en) Exothermic topical delivery device
AR042815A1 (es) Dispositivo de suministro de agente activo que tiene miembros compuestos
EP1194092B1 (de) Exothermes oberflächliches zuführungsgerät
BR9815378A (pt) Sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório compreendendo sal de dietilamÈnio diclofenac e o método de fabricação do mesmo.
NO993385D0 (no) Transdermalt terapeutisk system for avgivelse av hormoner
AR002262A1 (es) Composicion y metodo para el tratamiento de enfermedades fungales de las unas y un vendaje adaptado para la administracion topica de medicacion a lasunas.
ES2137993T3 (es) La utilizacion de glicerina para moderar el aporte transdermico de medicamentos.
BR0114909A (pt) Dispositivos de distribuição de drogas transdérmicas possuindo microprotuberâncias revestidas
ES2267706T3 (es) Agentes como la nicotinamida o cardr para el tratamiento de trastornos de la piel.
IL134269A (en) Anti-inflammatory bandage
AR042677A1 (es) Composiciones y metodos de cuidado oral
PE20040548A1 (es) Lamina revestida de adhesivo para administracion dermica de un inhibidor selectivo de ciclooxigenasa-2
AR019948A1 (es) Parche que contiene sustancia activa, para la emision controlada de estradiol o sus derivados farmaceuticamente inofensivos, y los usos del parche
PA8615501A1 (es) Formulaciones farmaceuticas transdermicas
US11510883B2 (en) Kit for delivery of an active compound into the skin
ES2102199T3 (es) Parche que contiene sustancia activa para la emision controlada de nitroglicerina a la piel, procedimiento de fabricacion y uso.
BR9916814A (pt) Composição cosmética pulverizável e matriz utilizável nessa composição para uma administração dérmica
DE60126591D1 (de) In-vitro-Verwendung von Astaxanthin zur Vorbehandlung von Zellen vor UV-Bestrahlung zwecks Hemmung der Aktivierung von NF-KB
ATE357219T1 (de) Darreichungsformen für dns
ES2188021T3 (es) Metodo para evitar el uso indebido de un sistema terapeutico percutaneo.
AR029664A1 (es) Parche portador de estrngenos con reservorio de sustancia activa a base de etilcelulosa y un copolemero de etileno, acetato de vinilo y vinilpirrolidona
AR016200A1 (es) El uso de una composicion que comprende uno o mas compuestos que contienen azufre para la fabricacion de un medicamento para aumentar la permeabilidad deltejido corneo humano, y un kit que incluye dicha composicion
AR020108A1 (es) Preparado para la aplicacion terapeutica percutanea de trinitrato de glicerol, un procedimiento para su preparacion y su empleo

Legal Events

Date Code Title Description
FA Abandonment or withdrawal